Trial Profile
Evaluation of the effect of the antiepiletic levetiracetum on seizure control and expression of MGMT in patients with gliomas (Phase II clinical trial)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 May 2015
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Glioma; Seizures
- Focus Therapeutic Use
- Acronyms LEV for Glioma
- 19 May 2015 New trial record